Difference between revisions of "Actinium Ac 225 lintuzumab (Actimab-A)"
Jump to navigation
Jump to search
m |
m (→Also know as) |
||
Line 5: | Line 5: | ||
===[[Acute myeloid leukemia]]=== | ===[[Acute myeloid leukemia]]=== | ||
− | ==Also | + | ==Also known as== |
*'''Brand name:''' Actimab-A | *'''Brand name:''' Actimab-A | ||
Revision as of 12:19, 4 December 2022
Mechanism of action
Monoclonal antibody directed against CD33 with a radioactive agent attached.
Preliminary data
Acute myeloid leukemia
Also known as
- Brand name: Actimab-A